← Eichor
Study identifier: NCT02993900 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Image-Guided Gynecologic Brachytherapy

Condition: Cervical Cancer · Uterine Cancer · Vaginal Cancer  ·  Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

PhaseNA
Planned participants54
Who can joinFemale, 18 Years to 100 Years
Healthy volunteersNo

About this study

This research is being done to evaluate multimodality imaging, including magnetic resonance imaging-guided therapy (MRT), as a possible treatment for gynecologic cancers. The therapy takes place in the Department of Radiation Oncology at the Johns Hopkins SKCCC. The purpose of this study is to investigate the ability of MRI to successfully guide the placement of the brachytherapy applicator necessary to treat participants' gynecologic cancer. The Investigators want to see if the use of MRI will do a better job of assessing the tumor at the time of brachytherapy than the routinely used CT scan. The Investigators also want to determine if the use of MRI will enable doctors to reduce the radiation dose received by the body during the process of treating the tumor.

This description comes directly from the study's public registry record.

Talk to the study team

Shirley DiPasquale, R.N.  ·  410-614-1598  ·  sdipasq1@jhmi.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The SKCCC at Johns HopkinsBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02993900